IHG
KYTX icon

Insight Holdings Group’s Kyverna Therapeutics KYTX Stock Holding History

Insight Holdings Group’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.81M Hold
989,054
– – 0.67% 24
2026
Q1 		$8.54M Hold
989,054
– – 0.6% 17
2025
Q4 		$9.3M Hold
989,054
– – 0.7% 15
2025
Q3 		$5.93M Hold
989,054
– – 0.37% 19
2025
Q2 		$3.04M Hold
989,054
– – 0.13% 28
2025
Q1 		$1.91M Buy
989,054
+76,139
+8% +$225K 0.15% 25
2024
Q4 		$3.41M Hold
912,915
– – 0.22% 23
2024
Q3 		$4.46M Hold
912,915
– – 0.19% 20
2024
Q2 		$6.85M Hold
912,915
– – 0.24% 18
2024
Q1 		$22.7M Buy
+912,915
New +$25.5M 0.63% 15

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Insight Holdings Group's KYTX Position: Q2 2026 in Review

Insight Holdings Group held its Kyverna Therapeutics (KYTX) position steady in Q2 2026 at 989,054 shares worth $8.81M. The position accounts for 0.67% of the portfolio, ranked #24.

Insight Holdings Group first reported a position in KYTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $22.7M in Q1 2024. 121 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Insight Holdings Group held 989,054 shares of Kyverna Therapeutics worth $8.81M as of Q2 2026.
  • Insight Holdings Group left its Kyverna Therapeutics share count unchanged in Q2 2026.
  • Kyverna Therapeutics made up 0.67% of Insight Holdings Group's portfolio in Q2 2026, its #24 holding.
  • Insight Holdings Group first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Insight Holdings Group's Kyverna Therapeutics position peaked at $22.7M in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Insight Holdings Group's 13F filing for Q2 2026, filed 14 Aug 2026.